TY - JOUR
T1 - Current status of uterus transplantation in primates and issues for clinical application
AU - Kisu, Iori
AU - Banno, Kouji
AU - Mihara, Makoto
AU - Suganuma, Nobuhiko
AU - Aoki, Daisuke
N1 - Funding Information:
I.K. has received grants from the Japanese Foundation for Research and Promotion of Endoscopy and Kanzawa Medical Research Foundation . K.B. is a consultant with Covidien, Japan, has provided expert testimony for Mochida Pharmaceutical Co., and has received grants from the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care and the Kobayashi Foundation for Cancer Research and payment for lectures from Mochida Pharmaceutical Co., Takeda Pharamceutical Co., Kissei Pharmaceutical Co., Fujiyakuhin Co., Nippon Shinyaku Co., Chugai Pharmaceutical Co., and Sanofi. M.M. has nothing to disclose. N.S. has received grants from Jex Co. , Tsumura & Co. , and Japan Chemical Research Pharmaceutical Co. and payment for lectures from Merck Serono Japan, MSD Co., Takeda Pharmaceutical Co., and Ferring Pharmaceuticals Co. D.A. has provided expert testimony for Astellas Pharma, Eisai Co., and GlaxoSmithKline and has received grants from Sanofi, Chugai Pharmaceutical Co. , and Bristol Myers , payment for manuscript preparation from GlaxoSmithKline, and payment for lectures from Kissei Pharmaceutical Co., GlaxoSmithKline, Sanofi, Shionogi & Co., and Fuji Pharma Co.
PY - 2013/7
Y1 - 2013/7
N2 - Objective: To clarify the current status of uterus transplantation (UT) and the medical, ethical, and social problems surrounding UT. Design: Systematic review. Setting: Not applicable. Patient(s): Mainly nonhuman primates and humans. Intervention(s): Not applicable. Main Outcome Measure(s): A systematic search of Pubmed with the terms "uterus/uterine transplantation" was performed for English-language articles to review the current status of UT and issues associated with its clinical application, with a focus on nonhuman primate and human studies on UT. Result(s): The first UT procedure in humans was conducted for a patient with absolute uterine infertility in Saudi Arabia in 2000. The transplanted uterus was removed after 99 days owing to prolapse and necrosis. That attempt led to a greater focus on basic UT experiments in animal models, including nonhuman primates. The subsequent accumulation of basic data has led to performance of UT in humans by groups in Turkey and Sweden. However, there has yet to be a pregnancy or delivery after allo-UT in primates. Moreover, there are many medical, ethical, and social problems that require examination before clinical application. Conclusion(s): Clinical application of UT has just begun, but more basic data are needed and medical, ethical, and social problems require thorough discussion before clinical application.
AB - Objective: To clarify the current status of uterus transplantation (UT) and the medical, ethical, and social problems surrounding UT. Design: Systematic review. Setting: Not applicable. Patient(s): Mainly nonhuman primates and humans. Intervention(s): Not applicable. Main Outcome Measure(s): A systematic search of Pubmed with the terms "uterus/uterine transplantation" was performed for English-language articles to review the current status of UT and issues associated with its clinical application, with a focus on nonhuman primate and human studies on UT. Result(s): The first UT procedure in humans was conducted for a patient with absolute uterine infertility in Saudi Arabia in 2000. The transplanted uterus was removed after 99 days owing to prolapse and necrosis. That attempt led to a greater focus on basic UT experiments in animal models, including nonhuman primates. The subsequent accumulation of basic data has led to performance of UT in humans by groups in Turkey and Sweden. However, there has yet to be a pregnancy or delivery after allo-UT in primates. Moreover, there are many medical, ethical, and social problems that require examination before clinical application. Conclusion(s): Clinical application of UT has just begun, but more basic data are needed and medical, ethical, and social problems require thorough discussion before clinical application.
KW - Mayer-Rokitansky-Küster-Hauser syndrome
KW - Uterus transplantation
KW - surrogacy
KW - uterine factor infertility
UR - http://www.scopus.com/inward/record.url?scp=84879695035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879695035&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2013.03.004
DO - 10.1016/j.fertnstert.2013.03.004
M3 - Article
C2 - 23557761
AN - SCOPUS:84879695035
SN - 0015-0282
VL - 100
SP - 280
EP - 294
JO - Fertility and Sterility
JF - Fertility and Sterility
IS - 1
ER -